Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Polycythemia associated with myeloma.

K Maeda, J Abraham

    American Journal of Clinical Pathology
    |October 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    This study describes four cases of polycythemia linked to myeloma, with three showing polycythemia vera and IgA monoclonal gammopathy. It explores the potential connection between myeloproliferative disorders and myeloma.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Validation of an AI-enabled exome/transcriptome liquid biopsy platform for early detection, MRD, disease monitoring, and therapy selection for solid tumors.

    Scientific reports·2025
    Same author

    Comparative histologic assessment of fetal cadaveric tissue preserved using the modified saturated salt solution.

    Morphologie : bulletin de l'Association des anatomistes·2025
    Same author

    Cost-effectiveness-analysis of oral health remotivation and reinstruction in nursing homes in a cluster-randomized controlled trial.

    Journal of dentistry·2024
    Same author

    Real-world data for marginal zone lymphoma patients in the French REALYSA cohort: The REALMA study.

    Hematological oncology·2024
    Same author

    Development of a shared decision-making intervention to improve drug safety and to reduce polypharmacy in frail elderly patients living at home.

    PEC innovation·2023
    Same author

    Determining degradation kinetics, byproducts and toxicity for the reductive treatment of Nitroguanidine (NQ) by magnesium-based bimetal Mg/Cu.

    Journal of hazardous materials·2021
    Same journal

    Communication patterns among surgical pathologists: a retrospective review of ideal strategies in a tertiary care setting.

    American journal of clinical pathology·2026
    Same journal

    Invasive urothelial carcinoma in association with surface low-grade papillary urothelial carcinoma: clinical and pathologic insights from a rare entity.

    American journal of clinical pathology·2026
    Same journal

    CEACAM1 expression by immunohistochemistry in B-cell lymphomas and plasma cell myeloma.

    American journal of clinical pathology·2026
    Same journal

    Comprehensive multicriteria life cycle assessment of biopsy processing in a surgical pathology department.

    American journal of clinical pathology·2026
    Same journal

    Prognostic significance of Myb protein and its downstream target genes in lacrimal gland adenoid cystic carcinoma.

    American journal of clinical pathology·2026
    Same journal

    Mismatch repair protein "nonclassic expression loss" pattern in colorectal cancer: an important staining pattern that is not well understood.

    American journal of clinical pathology·2026
    See all related articles

    Area of Science:

    • Hematology
    • Oncology
    • Immunology

    Background:

    • Multiple myeloma is a plasma cell malignancy.
    • Polycythemia vera is a myeloproliferative neoplasm characterized by increased red blood cell mass.
    • The co-occurrence of these conditions is rare and warrants investigation.

    Observation:

    • Four cases of polycythemia in patients with multiple myeloma are presented.
    • Three of these patients were diagnosed with polycythemia vera and IgA monoclonal gammopathy.
    • A literature review identified 11 similar cases, with four having prior 32P therapy for polycythemia vera.

    Findings:

    • The association between polycythemia vera and IgA monoclonal gammopathy in the context of multiple myeloma is highlighted.
    • The data suggests a potential link or shared underlying mechanisms between chronic myeloproliferative disorders and myeloma.

    Related Experiment Videos

  • Previous 32P therapy for polycythemia vera may be a factor in some cases.

    • Implications:

    • Understanding the relationship between myeloproliferative neoplasms and multiple myeloma can improve diagnostic and therapeutic strategies.
    • Further research is needed to elucidate the pathobiology underlying the co-occurrence of these hematologic malignancies.
    • This association may have implications for risk stratification and treatment decisions in patients with either condition.